Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obsessive-Compulsive Disorder | 101 | 2023 | 1444 | 14.270 |
Why?
|
Cycloserine | 7 | 2019 | 113 | 2.150 |
Why?
|
Tourette Syndrome | 16 | 2023 | 379 | 1.710 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 21 | 2023 | 3658 | 1.400 |
Why?
|
Implosive Therapy | 5 | 2021 | 120 | 1.340 |
Why?
|
Psychiatric Status Rating Scales | 38 | 2022 | 6038 | 1.200 |
Why?
|
Tic Disorders | 5 | 2023 | 127 | 1.160 |
Why?
|
Fear | 4 | 2019 | 1440 | 1.100 |
Why?
|
Extinction, Psychological | 3 | 2019 | 376 | 1.100 |
Why?
|
Child | 94 | 2023 | 77709 | 0.870 |
Why?
|
Trichotillomania | 1 | 2023 | 172 | 0.770 |
Why?
|
Adolescent | 87 | 2023 | 85781 | 0.750 |
Why?
|
Sensation Disorders | 2 | 2014 | 155 | 0.750 |
Why?
|
Anxiety Disorders | 13 | 2023 | 2690 | 0.730 |
Why?
|
Endophenotypes | 2 | 2021 | 250 | 0.710 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2019 | 16 | 0.700 |
Why?
|
Executive Function | 3 | 2017 | 1364 | 0.700 |
Why?
|
Phobic Disorders | 3 | 2019 | 439 | 0.660 |
Why?
|
Antimetabolites | 1 | 2018 | 125 | 0.630 |
Why?
|
Comorbidity | 32 | 2023 | 10388 | 0.610 |
Why?
|
Siblings | 1 | 2021 | 854 | 0.560 |
Why?
|
Hepatectomy | 1 | 2019 | 550 | 0.540 |
Why?
|
Age of Onset | 17 | 2017 | 3271 | 0.530 |
Why?
|
Psychometrics | 14 | 2022 | 3002 | 0.530 |
Why?
|
Combined Modality Therapy | 10 | 2022 | 8642 | 0.530 |
Why?
|
Cognition Disorders | 3 | 2021 | 4043 | 0.510 |
Why?
|
Obsessive Behavior | 5 | 2018 | 47 | 0.500 |
Why?
|
Sensation | 2 | 2014 | 336 | 0.490 |
Why?
|
Personality Assessment | 5 | 2021 | 647 | 0.460 |
Why?
|
Neurobiology | 1 | 2014 | 121 | 0.450 |
Why?
|
Severity of Illness Index | 29 | 2019 | 15540 | 0.440 |
Why?
|
Paroxetine | 2 | 2004 | 182 | 0.440 |
Why?
|
Propylamines | 3 | 2007 | 165 | 0.430 |
Why?
|
Parents | 5 | 2021 | 3407 | 0.430 |
Why?
|
Adrenergic Uptake Inhibitors | 3 | 2007 | 189 | 0.420 |
Why?
|
Family | 10 | 2023 | 3147 | 0.390 |
Why?
|
Psychomotor Performance | 2 | 2017 | 1901 | 0.370 |
Why?
|
Behavioral Symptoms | 1 | 2012 | 175 | 0.360 |
Why?
|
Neuropsychological Tests | 4 | 2021 | 6993 | 0.360 |
Why?
|
Humans | 131 | 2023 | 744343 | 0.350 |
Why?
|
Male | 88 | 2022 | 350118 | 0.340 |
Why?
|
Child Behavior Disorders | 4 | 2017 | 807 | 0.340 |
Why?
|
Occupational Therapy | 2 | 2023 | 134 | 0.320 |
Why?
|
Female | 83 | 2021 | 380194 | 0.300 |
Why?
|
Personality Inventory | 3 | 2021 | 1030 | 0.300 |
Why?
|
Compulsive Behavior | 3 | 2013 | 117 | 0.290 |
Why?
|
Depression | 5 | 2017 | 7766 | 0.280 |
Why?
|
Perinatal Care | 1 | 2008 | 227 | 0.280 |
Why?
|
Liver Neoplasms | 3 | 2019 | 4253 | 0.270 |
Why?
|
Life Change Events | 1 | 2010 | 938 | 0.260 |
Why?
|
Treatment Outcome | 25 | 2021 | 63114 | 0.250 |
Why?
|
Standard of Care | 2 | 2020 | 564 | 0.250 |
Why?
|
Fluoxetine | 2 | 2001 | 749 | 0.240 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2017 | 1953 | 0.230 |
Why?
|
Awareness | 3 | 2018 | 640 | 0.220 |
Why?
|
Double-Blind Method | 10 | 2019 | 12026 | 0.220 |
Why?
|
Quantitative Trait, Heritable | 2 | 2017 | 544 | 0.210 |
Why?
|
Adolescent Behavior | 2 | 2004 | 1151 | 0.200 |
Why?
|
Family Health | 3 | 2014 | 1282 | 0.200 |
Why?
|
Stroop Test | 1 | 2021 | 62 | 0.190 |
Why?
|
Sertraline | 2 | 1999 | 206 | 0.190 |
Why?
|
Desipramine | 2 | 2002 | 184 | 0.190 |
Why?
|
Family Relations | 3 | 2019 | 321 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 9 | 2021 | 17446 | 0.180 |
Why?
|
Self Report | 4 | 2019 | 3558 | 0.180 |
Why?
|
Dysgammaglobulinemia | 1 | 2019 | 21 | 0.170 |
Why?
|
Antidepressive Agents | 4 | 2019 | 2838 | 0.170 |
Why?
|
Models, Psychological | 2 | 2015 | 811 | 0.170 |
Why?
|
Anxiety | 5 | 2022 | 4297 | 0.170 |
Why?
|
Societies, Scientific | 1 | 2020 | 220 | 0.170 |
Why?
|
Child Behavior | 1 | 2004 | 839 | 0.160 |
Why?
|
Cost of Illness | 2 | 2019 | 1859 | 0.160 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2017 | 4266 | 0.150 |
Why?
|
Adult | 36 | 2023 | 214055 | 0.150 |
Why?
|
Adolescent Health Services | 1 | 2000 | 215 | 0.150 |
Why?
|
Tics | 3 | 2004 | 70 | 0.150 |
Why?
|
Interview, Psychological | 4 | 2011 | 812 | 0.150 |
Why?
|
Human Development | 1 | 1998 | 124 | 0.150 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2017 | 146 | 0.150 |
Why?
|
Pregnancy Complications | 3 | 2008 | 2861 | 0.140 |
Why?
|
N-Methylaspartate | 1 | 2017 | 231 | 0.140 |
Why?
|
Emotions | 4 | 2021 | 2661 | 0.140 |
Why?
|
Social Behavior Disorders | 1 | 1996 | 97 | 0.140 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2133 | 0.140 |
Why?
|
Bipolar Disorder | 3 | 2010 | 5027 | 0.140 |
Why?
|
Family Therapy | 1 | 2017 | 207 | 0.140 |
Why?
|
Conditioning, Classical | 1 | 2019 | 366 | 0.140 |
Why?
|
Quality of Life | 1 | 2017 | 12804 | 0.140 |
Why?
|
Problem Solving | 1 | 2018 | 440 | 0.130 |
Why?
|
Immunoglobulin A | 1 | 2019 | 992 | 0.130 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 662 | 0.130 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 647 | 0.130 |
Why?
|
Perception | 2 | 2014 | 1198 | 0.130 |
Why?
|
Behavior Therapy | 2 | 2017 | 865 | 0.120 |
Why?
|
Rehabilitation, Vocational | 1 | 2015 | 82 | 0.120 |
Why?
|
Reproducibility of Results | 9 | 2022 | 19905 | 0.120 |
Why?
|
Factor Analysis, Statistical | 3 | 2021 | 977 | 0.120 |
Why?
|
Placebos | 4 | 2004 | 1676 | 0.120 |
Why?
|
Radiology, Interventional | 1 | 1998 | 460 | 0.120 |
Why?
|
Child Health Services | 1 | 2000 | 667 | 0.120 |
Why?
|
Object Attachment | 1 | 2016 | 313 | 0.120 |
Why?
|
Case-Control Studies | 9 | 2021 | 21746 | 0.120 |
Why?
|
Multifactorial Inheritance | 2 | 2019 | 1194 | 0.110 |
Why?
|
Tumor Burden | 1 | 2019 | 1915 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 541 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 1998 | 1641 | 0.110 |
Why?
|
Streptococcal Infections | 1 | 2017 | 638 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2019 | 1301 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1003 | 0.110 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.110 |
Why?
|
Sex Factors | 8 | 2019 | 10397 | 0.110 |
Why?
|
Magnetoencephalography | 2 | 2007 | 623 | 0.100 |
Why?
|
Prevalence | 7 | 2019 | 15226 | 0.100 |
Why?
|
Age Factors | 11 | 2019 | 18370 | 0.100 |
Why?
|
Excitatory Amino Acid Transporter 3 | 1 | 2011 | 32 | 0.100 |
Why?
|
Genome-Wide Association Study | 8 | 2019 | 12261 | 0.100 |
Why?
|
Genetic Linkage | 2 | 2014 | 2421 | 0.100 |
Why?
|
Anxiety, Separation | 1 | 2011 | 86 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 895 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2015 | 409 | 0.090 |
Why?
|
Parenting | 1 | 2016 | 679 | 0.090 |
Why?
|
Genes, Homeobox | 1 | 2011 | 286 | 0.090 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2012 | 312 | 0.090 |
Why?
|
Depressive Disorder, Major | 3 | 2017 | 4644 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2017 | 2539 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2015 | 500 | 0.090 |
Why?
|
Chi-Square Distribution | 4 | 2009 | 3508 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2017 | 15519 | 0.090 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1941 | 0.090 |
Why?
|
Memory, Short-Term | 2 | 2007 | 975 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2959 | 0.090 |
Why?
|
Risk Factors | 11 | 2017 | 72290 | 0.080 |
Why?
|
Mental Disorders | 8 | 2019 | 6600 | 0.080 |
Why?
|
Psychological Tests | 1 | 2011 | 651 | 0.080 |
Why?
|
Depressive Disorder | 2 | 1999 | 3748 | 0.080 |
Why?
|
Sensory Gating | 1 | 2008 | 47 | 0.080 |
Why?
|
Amygdala | 1 | 2016 | 1315 | 0.080 |
Why?
|
Glutamic Acid | 1 | 2014 | 1169 | 0.080 |
Why?
|
Perinatology | 1 | 2008 | 57 | 0.080 |
Why?
|
Rheumatic Fever | 1 | 2008 | 71 | 0.080 |
Why?
|
Young Adult | 11 | 2019 | 56430 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10943 | 0.080 |
Why?
|
Methylphenidate | 1 | 2012 | 473 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3610 | 0.080 |
Why?
|
Environment | 1 | 2014 | 1124 | 0.080 |
Why?
|
Caregivers | 1 | 2019 | 2094 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2000 | 3528 | 0.080 |
Why?
|
Visual Perception | 2 | 2007 | 1420 | 0.080 |
Why?
|
Brain | 1 | 2014 | 26385 | 0.070 |
Why?
|
Alpha Rhythm | 1 | 2007 | 120 | 0.070 |
Why?
|
Body Weight | 2 | 2016 | 4669 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2002 | 434 | 0.070 |
Why?
|
Cognition | 3 | 2021 | 6770 | 0.070 |
Why?
|
Dopamine | 1 | 2014 | 1591 | 0.070 |
Why?
|
Boston | 3 | 2016 | 9313 | 0.070 |
Why?
|
Interpersonal Relations | 1 | 2014 | 1425 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 25043 | 0.070 |
Why?
|
Antimanic Agents | 1 | 2010 | 522 | 0.070 |
Why?
|
Length of Stay | 1 | 2019 | 6309 | 0.070 |
Why?
|
Phenotype | 5 | 2013 | 16365 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2016 | 2585 | 0.070 |
Why?
|
Growth | 1 | 2007 | 376 | 0.070 |
Why?
|
Indans | 1 | 2006 | 96 | 0.070 |
Why?
|
Middle Aged | 17 | 2019 | 213383 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3743 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 1998 | 916 | 0.060 |
Why?
|
Cholinesterase Inhibitors | 1 | 2006 | 238 | 0.060 |
Why?
|
Clomipramine | 1 | 2003 | 54 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2023 | 7279 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2010 | 1101 | 0.060 |
Why?
|
Massachusetts | 3 | 2004 | 8663 | 0.060 |
Why?
|
Aged | 13 | 2019 | 163280 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2007 | 455 | 0.060 |
Why?
|
Pediatrics | 2 | 2015 | 3475 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 1998 | 2948 | 0.050 |
Why?
|
Arousal | 1 | 2008 | 1165 | 0.050 |
Why?
|
Communication | 2 | 2014 | 3749 | 0.050 |
Why?
|
Sampling Studies | 1 | 2003 | 623 | 0.050 |
Why?
|
Social Participation | 1 | 2023 | 173 | 0.050 |
Why?
|
Drug Interactions | 1 | 2006 | 1460 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2002 | 12959 | 0.050 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2006 | 615 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
Consumer Product Safety | 1 | 2001 | 122 | 0.050 |
Why?
|
Least-Squares Analysis | 1 | 2001 | 379 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 9959 | 0.050 |
Why?
|
Odds Ratio | 2 | 2010 | 9849 | 0.050 |
Why?
|
Linear Models | 1 | 2010 | 5952 | 0.050 |
Why?
|
Observer Variation | 1 | 2006 | 2593 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2006 | 956 | 0.040 |
Why?
|
Reward | 1 | 2006 | 941 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2373 | 0.040 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 1979 | 92 | 0.040 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 1979 | 189 | 0.040 |
Why?
|
Research | 1 | 2007 | 1999 | 0.040 |
Why?
|
Twins | 1 | 2019 | 339 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 40075 | 0.040 |
Why?
|
Attention | 1 | 2008 | 2400 | 0.040 |
Why?
|
Piperidines | 1 | 2006 | 1602 | 0.040 |
Why?
|
Compulsive Personality Disorder | 1 | 2017 | 48 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 8987 | 0.040 |
Why?
|
Sex Distribution | 2 | 2001 | 2297 | 0.040 |
Why?
|
Psychotherapy | 1 | 2006 | 1643 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2014 | 1504 | 0.040 |
Why?
|
Administration, Oral | 1 | 2004 | 3913 | 0.040 |
Why?
|
British Columbia | 1 | 2016 | 244 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 7913 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 1998 | 694 | 0.030 |
Why?
|
Wechsler Scales | 1 | 1996 | 260 | 0.030 |
Why?
|
Laboratory Infection | 1 | 1995 | 7 | 0.030 |
Why?
|
Social Adjustment | 1 | 1998 | 631 | 0.030 |
Why?
|
Hemorrhagic Fever, American | 1 | 1995 | 12 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2006 | 15076 | 0.030 |
Why?
|
Arenaviruses, New World | 1 | 1995 | 34 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 949 | 0.030 |
Why?
|
Mood Disorders | 2 | 2000 | 1106 | 0.030 |
Why?
|
Follow-Up Studies | 6 | 2014 | 39050 | 0.030 |
Why?
|
Suicide | 1 | 2006 | 1477 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2540 | 0.030 |
Why?
|
Child, Preschool | 7 | 2017 | 41006 | 0.030 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2014 | 24 | 0.030 |
Why?
|
Pregnancy | 3 | 2008 | 29144 | 0.030 |
Why?
|
Recurrence | 2 | 2004 | 8340 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2418 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4933 | 0.030 |
Why?
|
Ribavirin | 1 | 1995 | 395 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 1998 | 1276 | 0.030 |
Why?
|
Hydrocephalus | 1 | 1979 | 748 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1792 | 0.030 |
Why?
|
Personality Disorders | 1 | 2017 | 713 | 0.030 |
Why?
|
Age Distribution | 1 | 1998 | 2902 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2001 | 6365 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2014 | 535 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2564 | 0.030 |
Why?
|
Social Class | 2 | 2001 | 1999 | 0.030 |
Why?
|
Benchmarking | 1 | 2018 | 1042 | 0.030 |
Why?
|
Dependent Personality Disorder | 1 | 2011 | 13 | 0.020 |
Why?
|
Parietal Lobe | 2 | 2007 | 838 | 0.020 |
Why?
|
Celiac Disease | 1 | 2019 | 785 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23403 | 0.020 |
Why?
|
Syndrome | 1 | 2017 | 3251 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2017 | 57776 | 0.020 |
Why?
|
Agoraphobia | 1 | 2011 | 179 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14722 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2011 | 373 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5255 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1783 | 0.020 |
Why?
|
Equipment Design | 1 | 1998 | 3582 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2015 | 1997 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2703 | 0.020 |
Why?
|
Liver | 3 | 1997 | 7474 | 0.020 |
Why?
|
Brazil | 2 | 2009 | 1270 | 0.020 |
Why?
|
Neoplasms | 1 | 1998 | 21683 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 658 | 0.020 |
Why?
|
Perioperative Period | 1 | 2010 | 256 | 0.020 |
Why?
|
Central Nervous System Stimulants | 2 | 2012 | 1148 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1656 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2012 | 968 | 0.020 |
Why?
|
Hemodynamics | 1 | 1999 | 4199 | 0.020 |
Why?
|
Cholic Acids | 1 | 1988 | 41 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15295 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12951 | 0.020 |
Why?
|
Infection Control | 1 | 1995 | 966 | 0.020 |
Why?
|
Prospective Studies | 5 | 2019 | 53288 | 0.020 |
Why?
|
Trans-Activators | 1 | 1997 | 2924 | 0.020 |
Why?
|
Cortical Synchronization | 1 | 2007 | 79 | 0.020 |
Why?
|
Self-Assessment | 1 | 2009 | 390 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Regression Analysis | 2 | 2009 | 6459 | 0.020 |
Why?
|
Panic Disorder | 1 | 2011 | 616 | 0.020 |
Why?
|
Radiography | 1 | 1998 | 7023 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1996 | 2132 | 0.020 |
Why?
|
Patient Care Team | 1 | 1998 | 2531 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7149 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3588 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.020 |
Why?
|
Logistic Models | 1 | 2001 | 13408 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2007 | 379 | 0.020 |
Why?
|
Prefrontal Cortex | 2 | 2007 | 2147 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2019 | 77449 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 5987 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1996 | 2708 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3920 | 0.020 |
Why?
|
Genetic Markers | 1 | 2011 | 2634 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2007 | 964 | 0.020 |
Why?
|
Risk Assessment | 1 | 2006 | 23338 | 0.020 |
Why?
|
Apoptosis | 2 | 1998 | 9727 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 1999 | 11031 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2779 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 1995 | 6489 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2011 | 1782 | 0.010 |
Why?
|
Models, Genetic | 1 | 2014 | 3494 | 0.010 |
Why?
|
Universities | 1 | 2009 | 956 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2006 | 940 | 0.010 |
Why?
|
Aggression | 1 | 2006 | 753 | 0.010 |
Why?
|
Evoked Potentials | 1 | 2007 | 1056 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1999 | 6364 | 0.010 |
Why?
|
Reaction Time | 1 | 2007 | 2097 | 0.010 |
Why?
|
Body Height | 1 | 2007 | 1577 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18029 | 0.010 |
Why?
|
Prognosis | 3 | 2009 | 29063 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 35421 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6773 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6544 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1998 | 6314 | 0.010 |
Why?
|
Life Tables | 1 | 1999 | 370 | 0.010 |
Why?
|
Social Behavior | 1 | 2006 | 1127 | 0.010 |
Why?
|
Haloperidol | 1 | 2000 | 397 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1988 | 2969 | 0.010 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2000 | 304 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7880 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9438 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2007 | 13989 | 0.010 |
Why?
|
Functional Laterality | 1 | 2004 | 2290 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 1997 | 159 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1998 | 772 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 1998 | 534 | 0.010 |
Why?
|
North America | 1 | 2000 | 1249 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2006 | 2057 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12788 | 0.010 |
Why?
|
Universal Precautions | 1 | 1995 | 34 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1996 | 475 | 0.010 |
Why?
|
Specialization | 1 | 2000 | 777 | 0.010 |
Why?
|
Health Status | 1 | 2008 | 4034 | 0.010 |
Why?
|
Patient Isolation | 1 | 1995 | 100 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1998 | 2085 | 0.010 |
Why?
|
Electroconvulsive Therapy | 1 | 1979 | 477 | 0.010 |
Why?
|
Europe | 1 | 2000 | 3339 | 0.010 |
Why?
|
Animals | 4 | 2019 | 168757 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1998 | 1224 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5102 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1097 | 0.010 |
Why?
|
Contact Tracing | 1 | 1995 | 273 | 0.010 |
Why?
|
Nerve Net | 1 | 2004 | 2174 | 0.010 |
Why?
|
Patient Admission | 1 | 2000 | 1380 | 0.010 |
Why?
|
Medicine | 1 | 2000 | 946 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1996 | 1213 | 0.010 |
Why?
|
Cells, Cultured | 2 | 1997 | 19229 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8949 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1998 | 2382 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12720 | 0.010 |
Why?
|
Electroencephalography | 1 | 2004 | 6150 | 0.010 |
Why?
|
Safety Management | 1 | 1995 | 783 | 0.010 |
Why?
|
Methylcholanthrene | 1 | 1988 | 29 | 0.010 |
Why?
|
Propane | 1 | 1988 | 11 | 0.010 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 1988 | 31 | 0.010 |
Why?
|
Quinone Reductases | 1 | 1988 | 18 | 0.010 |
Why?
|
Cholic Acid | 1 | 1988 | 34 | 0.010 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 1988 | 46 | 0.010 |
Why?
|
Down-Regulation | 1 | 1996 | 3002 | 0.010 |
Why?
|
Carbon Tetrachloride | 1 | 1988 | 64 | 0.000 |
Why?
|
Neovascularization, Pathologic | 1 | 1998 | 2635 | 0.000 |
Why?
|
Heart Rate | 1 | 1999 | 4091 | 0.000 |
Why?
|
Colon | 1 | 1996 | 1772 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1998 | 3508 | 0.000 |
Why?
|
Phenobarbital | 1 | 1988 | 193 | 0.000 |
Why?
|
NADP | 1 | 1988 | 226 | 0.000 |
Why?
|
Fibroblasts | 1 | 1997 | 4161 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 2000 | 3057 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1988 | 2186 | 0.000 |
Why?
|
Survival Analysis | 1 | 1999 | 10252 | 0.000 |
Why?
|
DNA Damage | 1 | 1996 | 2432 | 0.000 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1988 | 419 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1999 | 12245 | 0.000 |
Why?
|
Protein Binding | 1 | 1997 | 9386 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1999 | 12354 | 0.000 |
Why?
|
Cytosol | 1 | 1988 | 901 | 0.000 |
Why?
|
Repressor Proteins | 1 | 1996 | 3023 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5867 | 0.000 |
Why?
|
Disease Progression | 1 | 2000 | 13284 | 0.000 |
Why?
|
Blood Pressure | 1 | 1999 | 8554 | 0.000 |
Why?
|
United States | 1 | 2009 | 69872 | 0.000 |
Why?
|
Mice | 2 | 1998 | 81183 | 0.000 |
Why?
|
Pharmaceutical Preparations | 1 | 1988 | 1071 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 12072 | 0.000 |
Why?
|
Rats | 1 | 1988 | 24260 | 0.000 |
Why?
|